Glaxosmithkline Plc Adrf - GSK (GSK)

CUSIP: 37733W105

Q4 2024 13F Holders as of 31 Dec 2024

Share change
-183,454
SEC-reported price per share
$33.82
Number of holders
6
Value change
-$6,268,697
Number of sells
3

Security key

37733W105

Report period

Q4 2024

Institutions

6

Top holders

6

Ownership snapshot

Top reported holders of GSK - Glaxosmithkline Plc Adrf - GSK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BlackRock, Inc.
Disclosed value leader
BlackRock, Inc.
Comparable rows
1/15
Latest evidence
31 Dec 2024
13D/G 13F Lead comparable stake: 8.9% 14 rows are not safely comparable across share classes. 13D/G row: BlackRock, Inc. Showing 1-6 of 15 holder rows.

Quick read

BlackRock, Inc. leads the comparable SEC ownership view at 8.9%.

1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BlackRock, Inc.'s linked filing trail.
Comparable ownership Top 1
BlackRock, Inc. 8.9%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BlackRock, Inc.
13D/G 13F
Company
8.9%
Reported 13D/G · 31 Dec 2024
$6,226,766,199
369,576,114 shares
$0 31 Dec 2024
DODGE & COX
13F
Company
13F
—
denominator unverified
$2,783,403,223
68,087,163 shares
— 30 Sep 2024
JTC Employer Solutions Trustee Ltd
13F
Company
13F
—
denominator unverified
$837,364,000
20,480,962 shares
— 30 Sep 2024
Fisher Asset Management, LLC
13F
Company
13F
—
denominator unverified
$759,424,925
18,576,930 shares
— 30 Sep 2024
PRIMECAP MANAGEMENT CO/CA/
13F
Company
13F
—
denominator unverified
$607,221,502
14,853,755 shares
— 30 Sep 2024
MORGAN STANLEY
13F
Company
13F
—
denominator unverified
$325,152,779
7,953,833 shares
— 30 Sep 2024
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
6
Shares
887,129
Rows available
6
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2024 vs Q2 2026 Across Filers

Q2 2026 holders
4
Q4 2024 holders
6
Holder diff
2
Investor Q2 2026 Shares Q4 2024 Shares Share Diff Share Chg % Q2 2026 value Q4 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .